Zdrowie i gospodarka · 12/06/2014
FDA Clears AZO GANTANOL and AZO GANTRISIN for Sale
The FDA has determined that two urinary tract medications, AZO GANTANOL and AZO GANTRISIN, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.